§ 277 — Review and reports

New York § 277

• Jurisdiction: New York
• Law PBH: Public Health
• Title 1: Preferred Drug and Clinical Drug Review Programs
• Art. 2-A: Prescription Drugs

Text

§ 277. Review and reports. 1. The commissioner, in consultation with\nthe drug utilization review board, shall undertake periodic reviews, at\nleast annually, of the preferred drug program which shall include\nconsideration of:\n (a) the volume of prior authorizations being handled, including data\non the number and characteristics of prior authorization requests for\nparticular prescription drugs;\n (b) the quality of the program's responsiveness, including the quality\nof the administrator's responsiveness;\n (c) complaints received from patients and providers;\n (d) the savings attributable to the state, and to each county and the\ncity of New York, due to the provisions of this article;\n (e) the aggregate amount of supplemental rebates received in the\nprevious fiscal year and in the current fiscal year, to date; and such\namounts are to be broken out by fiscal year and by month;\n (f) the education and outreach program established by section two\nhundred seventy-six of this article.\n 2. The commissioner and the board shall, beginning March thirty-first,\ntwo thousand six and annually thereafter, submit a report to the\ngovernor and the legislature concerning each of the items subject to\nperiodic review under subdivision one of this section.\n 3. The commissioner and the board shall, beginning with the\ncommencement of the preferred drug program and monthly thereafter,\nsubmit a report to the governor and the legislature concerning the\namount of supplemental rebates received.\n